We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current TXG market cap is 3.14B. The company's latest EPS is USD -2.1407 and P/E is -12.33.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 134.29M | 146.82M | 153.64M | 183.98M | 141.01M |
| Operating Income | -51.99M | -63.36M | -94.8M | -50.29M | -61.5M |
| Net Income | -50.75M | -62.41M | -92.99M | -48.95M | -59.95M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 245.89M | 298.85M | 491.15M | 516.41M | 618.73M |
| Operating Income | -30.57M | -534.14M | -52.25M | -167.94M | -260.43M |
| Net Income | -31.25M | -542.73M | -58.22M | -166M | -255.1M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 1.01B | 989.64M | 948.54M | 965.14M | 922.91M |
| Total Liabilities | 211.65M | 196.34M | 203.32M | 224.1M | 204.08M |
| Total Equity | 802.39M | 793.3M | 745.22M | 741.04M | 718.83M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 605.92M | 929.34M | 1.02B | 1.03B | 965.14M |
| Total Liabilities | 185.84M | 190.27M | 201.26M | 223.24M | 224.1M |
| Total Equity | 420.08M | 739.07M | 817.57M | 805.74M | 741.04M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -4.13M | -15.65M | -40.96M | -15.2M | -15.73M |
| Investing | 119.96M | 115.49M | 120.39M | 133.49M | 10.63M |
| Financing | -3.41M | 3.68M | 8.06M | 13.67M | 1.64M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 34.63M | -217.9M | -21.37M | -33.61M | -15.2M |
| Investing | -42.77M | -38.39M | -106.73M | -350.89M | 133.49M |
| Financing | 414.59M | 468.91M | 35.3M | 15.82M | 13.67M |
| Market Cap | 3.14B |
| Price to Earnings Ratio | -12.33 |
| Price to Sales Ratio | 5.08 |
| Price to Cash Ratio | 8.75 |
| Price to Book Ratio | 4.24 |
| Dividend Yield | - |
| Shares Outstanding | 119.17M |
| Average Volume (1 week) | 1.93M |
| Average Volume (1 Month) | 2.16M |
| 52 Week Change | -51.87% |
| 52 Week High | 63.57 |
| 52 Week Low | 24.60 |
| Spread (Intraday) | 6.51 (20.36%) |
| Company Name | 10x Genomics Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.10xgenomics.com |
| Industry | lab analytical instruments (3826) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
